Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1216414.RAY_Y40Dqye8Wa3kCrpnkGlPssxy-C69jlKOMIhGC9bH4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1216414.RAY_Y40Dqye8Wa3kCrpnkGlPssxy-C69jlKOMIhGC9bH4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1216414.RAY_Y40Dqye8Wa3kCrpnkGlPssxy-C69jlKOMIhGC9bH4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1216414.RAY_Y40Dqye8Wa3kCrpnkGlPssxy-C69jlKOMIhGC9bH4130_provenance.
- NP1216414.RAY_Y40Dqye8Wa3kCrpnkGlPssxy-C69jlKOMIhGC9bH4130_assertion description "[In multivariate analysis, concomitant use of fluconazole for candidiasis was the only factor associated with reduced risk for hepatotoxicity (adjusted odds ratio, 0.372; 95% confidence interval, 0.145-0.957), while serostatus of hepatitis B or C virus, NAT1 and NAT2 acetylator types, or receipt of combination antiretroviral therapy was not.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216414.RAY_Y40Dqye8Wa3kCrpnkGlPssxy-C69jlKOMIhGC9bH4130_provenance.
- NP1216414.RAY_Y40Dqye8Wa3kCrpnkGlPssxy-C69jlKOMIhGC9bH4130_assertion evidence source_evidence_literature NP1216414.RAY_Y40Dqye8Wa3kCrpnkGlPssxy-C69jlKOMIhGC9bH4130_provenance.
- NP1216414.RAY_Y40Dqye8Wa3kCrpnkGlPssxy-C69jlKOMIhGC9bH4130_assertion SIO_000772 25184238 NP1216414.RAY_Y40Dqye8Wa3kCrpnkGlPssxy-C69jlKOMIhGC9bH4130_provenance.
- NP1216414.RAY_Y40Dqye8Wa3kCrpnkGlPssxy-C69jlKOMIhGC9bH4130_assertion wasDerivedFrom befree-2016 NP1216414.RAY_Y40Dqye8Wa3kCrpnkGlPssxy-C69jlKOMIhGC9bH4130_provenance.
- NP1216414.RAY_Y40Dqye8Wa3kCrpnkGlPssxy-C69jlKOMIhGC9bH4130_assertion wasGeneratedBy ECO_0000203 NP1216414.RAY_Y40Dqye8Wa3kCrpnkGlPssxy-C69jlKOMIhGC9bH4130_provenance.
- befree-2016 importedOn "2016-02-19" NP1216414.RAY_Y40Dqye8Wa3kCrpnkGlPssxy-C69jlKOMIhGC9bH4130_provenance.